HOME >> MEDICINE >> NEWS
Pioglitazone shown to reverse thickening of carotid artery wall

Mainz, Germany, November 9, 2004 Clinical study results presented today in New Orleans, Louisiana, during the American Heart Association's Scientific Sessions 2004 proceedings, have shown that the drug pioglitazone (ACTOS, Takeda) significantly reduced the thickness of the carotid (neck) artery in patients with type 2 diabetes. By contrast, no change in carotid thickness was seen in a group of patients who received glimepiride, an older drug for type 2 diabetes.

"These results are provocative, because both drugs showed similar effects on lowering blood glucose, the traditional principal target for type 2 diabetes therapy," noted principal investigator Thomas Forst, Professor for Internal Medicine, Institute for Clinical Research and Development in Mainz, Germany.

"The thickness of the carotid artery is an indicator of atherosclerotic disease, which may both reduce arterial blood flow and set the stage for unstable blood clots in the arteries to dislodge and potentially cause a heart attack or stroke. The reduction in thickness by pioglitazone, a member of a new class of type 2 diabetes drugs called thiazolidinediones (TZDs) suggests that this medication may have benefits beyond improving metabolic control in patients with diabetes mellitus type 2," continued Forst. "This substantial regression of carotid intima media thickness over just 12 or 24 weeks may have important prognostic implications for patients with type 2 diabetes."

Study Design and Results

In the study, B-mode ultrasound was used to measure the intima media thickness (IMT) of the carotid artery before and 12 and 24 weeks after 173 patients received oral therapy with either pioglitazone (45 mg/day) or glimepiride (1-6 mg/day). Baseline carotid IMT was 0.949 0.149mm in the pioglitazone group and 0.924 0.150mm in the glimepiride group (p=n.s.). Carotid IMT was reduced only in the pioglitazone group after 12 weeks (-0.033 0.052mm) vs. -0.002 0.047mm
'"/>

Contact: Kate Sullivan
646-284-6514
Ketchum
9-Nov-2004


Page: 1 2

Related medicine news :

1. Pioglitazone HCI shown to lower blood pressure in hypertensive patients with type 2 diabetes
2. Cartilage repair techniques shown to restore patient mobility and reduce pain
3. Sprinklers shown effective in slowing dorm fires
4. Controversial drug shown to act on brain protein to cut alcohol use
5. HPV vaccine shown effective at reducing cancer-causing infections
6. HPV vaccine shown to substantially reduce cervical cancer
7. New research results: Heart jacket shown to be effective
8. Isolated soy protein shown to benefit type 2 diabetics, study indicates
9. Increased risk of cardiovascular disease shown in PCOS patients
10. Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
11. Anti-eosinophil therapy shown to be effective in treating hypereosinophilic syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pioglitazone shown reverse thickening carotid artery wall

(Date:5/29/2015)... organizational consultant and part-time college professor, Dr. Ben Parks ... be suffering from early dementia. He is embarrassed at ... his uncertain relationship with his wife Addie. , Ben ... and government movers and shakers as they wrestle with ... are being diagnosed with Alzheimer’s, Ben wonders what’s in ...
(Date:5/29/2015)... 29, 2015 The world of dentistry had ... depicted dentists as sadists who dispense pain to people unfortunate ... What's more, when it came to surgeries, people would have ... ­ but that's all back in the 20th Century now. ... practice in the Sheepshead Bay neighborhood of Brooklyn, ...
(Date:5/29/2015)... DISC, a method of behavioral analysis that ... used by companies to improve hiring practices, streamline training, ... an out-of-the-box practice, has now become an integral part ... Society for Human Resource Management found that over 70% ... be an essential part of the hiring process, and ...
(Date:5/29/2015)... Hurst, Texas (PRWEB) May 29, 2015 Testosterone ... in the DFW area, is opening a new center in ... and the rest of the Mid Cities. Located on the ... Line Road in Hurst, the new testosterone center will open ... and women who suffer from low testosterone. , Like TCT’s ...
(Date:5/29/2015)... 2015 Wimbledon Health Partners, the leading ... echocardiogram and NCV testing, is proud to announce ... for EKG interpretation of athletes. , Sudden ... during athletic activity. New findings presented in February have ... improve cardiac safety in athletes. Physiologic adaptations in athletic ...
Breaking Medicine News(10 mins):Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 3Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 4Health News:PeopleKeys to Air a Follow-up to Their Popular DISC Trainer’s Toolbox Webinar, Featuring All-New Content and Strategies 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 3
(Date:5/28/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report  "Personalized Medicine ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The aim ... to match the right drug to the ... to design the appropriate treatment for a ...
(Date:5/28/2015)... ALEXANDRIA, Va. , May 28, 2015 ... Hoey , RPh, MBA issued the following statement in ... the AARP Public Policy Institute documenting that a number ... "This new report tracks with concerns previously expressed ... Congress to support patient access to essential medications. Moreover, ...
(Date:5/28/2015)... YORK , May 27, 2015 The ... $416 billion in 2014 and with growth of 8% ... three categories out of pocket: directly on expenditures, co-pays ... drug purchases, and on premiums.  The publisher made its ... Expenditures in the United States ...
Breaking Medicine Technology:Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3
Cached News: